Gyeonggi-do, South Korea

Dong Oh Yoon



 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Dong Oh Yoon: Pioneering Heterocyclic Compounds for Medical Advancements

Introduction

Dong Oh Yoon, a notable inventor based in Gyeonggi-do, South Korea, has made significant contributions to the field of medicinal chemistry. With a focus on developing innovative compounds, Yoon holds a patent that addresses various medical conditions through targeted therapeutic applications.

Latest Patents

Dong Oh Yoon's singular patent is titled "Substituted tricyclic heterocycles as histamine 4 receptor inhibitors." This invention relates to novel heterocyclic compounds that are beneficial in the formulation of drugs aimed at treating diseases tied to the functions of the histamine 4 receptor. These compounds have potential applications in the treatment of a wide range of conditions, including inflammatory diseases, allergies, pain, asthma, and various autoimmune disorders, among others.

Career Highlights

Yoon is currently affiliated with C&C Research Laboratories, where he dedicates his expertise to innovative research and development. His work at this laboratory reflects his commitment to advancing medical science through the discovery of new therapeutic agents.

Collaborations

In his professional journey, Yoon collaborates with esteemed colleagues, including Pil Su Ho and Sun Young Han. Their combined efforts contribute to the collective objective of enhancing drug efficacy and addressing unmet medical needs.

Conclusion

Dong Oh Yoon exemplifies the essence of innovation in the pharmaceutical field. With his groundbreaking work on heterocyclic compounds, he positions himself at the forefront of research that has the potential to transform treatment methodologies for numerous diseases. His contributions not only underscore the importance of intellectual property but also highlight the collaborative spirit of scientific inquiry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…